Royalty Pharma is trading 4.4% down at $55.88 in after-hours trading following the release of a fresh company update or earnings report after the closing bell.
- The stock previously closed the regular session at $58.43.
- The downward move is likely amplified by thin after-hours liquidity and wider bid-ask spreads typical of extended trading sessions.